title: Synthesis, characterisation and antitumour activity of some quercetin analogues.
abstract: Quercetin is one of the most abundant naturally occurring flavonoid and is associated with a wide range of biological activities, such as antioxidant, antiinflammatory and anticancer activities. However, there are multiple problems associated with the bioavailability of quercetin, thereby restricting its use. Taking this into consideration, the structure of quercetin was modified by removal of multiple hydroxyl groups and introduction of substituents such as Cl, OCH3 and N (CH3)2 on the p-position of the B-ring. The effect of structural modification on the anticancer activity was studied using four different cell lines, including MCF-7, HepG2, HCT-15 and PC-3. Compound 1a has shown an activity better than quercetin in HepG2 cell lines, whereas 1c and 1e showed significant growth inhibition of the HCT-15 cell lines.
authors.affiliation: Prin. K. M. Kundnani College of Pharmacy, Jote Joy Building, Rambhau Salgaonkar Road, Cuffe Parade, India.
authors.forename: M K
authors.initials: MK
authors.lastname: Gadhwal
authors.forename: Swati
authors.initials: S
authors.lastname: Patil
authors.forename: Priscilla
authors.initials: P
authors.lastname: D'Mello
authors.forename: Urmila
authors.initials: U
authors.lastname: Joshi
authors.forename: Ragini
authors.initials: R
authors.lastname: Sinha
authors.forename: G
authors.initials: G
authors.lastname: Govil
keywords: Anticancer activity; quercetin; structural modifications
references.citation: Biochem Pharmacol. 1983 Apr 1;32(7):1141-8
references.pmid: 6342623
references.citation: World J Gastroenterol. 2003 Jan;9(1):73-8
references.pmid: 12508355
references.citation: Chem Res Toxicol. 1996 Dec;9(8):1305-12
references.pmid: 8951233
references.citation: J Immunol Methods. 1997 Oct 27;208(2):151-8
references.pmid: 9433470
references.citation: Methods Mol Med. 2005;110:39-48
references.pmid: 15901925
references.citation: Cancer Lett. 1996 Dec 20;110(1-2):41-8
references.pmid: 9018079
references.citation: Int J Oncol. 2003 Jan;22(1):159-64
references.pmid: 12469199
references.citation: Carcinogenesis. 2001 Mar;22(3):409-14
references.pmid: 11238180
references.citation: Pharm Res. 2005 Jul;22(7):1050-8
references.pmid: 16028005
references.citation: Arch Biochem Biophys. 1994 Jan;308(1):278-84
references.pmid: 8311465
references.citation: Clin Cancer Res. 1996 Apr;2(4):659-68
references.pmid: 9816216
references.citation: Oncol Rep. 1997 Sep-Oct;4(5):1021-4
references.pmid: 21590187
references.citation: Int J Cancer. 1992 Feb 1;50(3):486-92
references.pmid: 1735617
references.citation: Crit Rev Food Sci Nutr. 2004;44(6):453-64
references.pmid: 15615428
references.citation: Food Chem Toxicol. 1995 Dec;33(12):1061-80
references.pmid: 8847003
references.citation: Nutr Cancer. 1999;35(2):175-9
references.pmid: 10693172
references.citation: FEBS Lett. 1997 Nov 24;418(1-2):152-6
references.pmid: 9414116
references.citation: Cancer Chemother Pharmacol. 1994;34(6):459-64
references.pmid: 7923555
references.citation: J Pharm Pharm Sci. 2004 Dec 20;8(1):1-9
references.pmid: 15946592
references.citation: J Biol Chem. 1956 Nov;223(1):251-7
references.pmid: 13376593